
Navis Bio is a company transforming drug design and development through AI-powered translational medicine. They leverage large language models (LLMs) and AI agents to automate manual analyst tasks, focusing on gathering scientific and competitive intelligence. Their solutions provide competitive intelligence by sifting through vast data sources to identify trends, assess therapeutic targets by integrating bioinformatics and personal discovery data, and optimize the positioning of therapeutic assets by analyzing mechanism of action and patient populations. Navis Bio offers a flexible software infrastructure, customizable for specific data and scientific needs, and employs AI orchestration at scale to process hundreds of references in parallel, from data retrieval and structuring to results summarization and continuous monitoring. Their ultimate goal is to accelerate the process of identifying the right therapeutic target, patient population, and biomarkers for drug development.

Navis Bio is a company transforming drug design and development through AI-powered translational medicine. They leverage large language models (LLMs) and AI agents to automate manual analyst tasks, focusing on gathering scientific and competitive intelligence. Their solutions provide competitive intelligence by sifting through vast data sources to identify trends, assess therapeutic targets by integrating bioinformatics and personal discovery data, and optimize the positioning of therapeutic assets by analyzing mechanism of action and patient populations. Navis Bio offers a flexible software infrastructure, customizable for specific data and scientific needs, and employs AI orchestration at scale to process hundreds of references in parallel, from data retrieval and structuring to results summarization and continuous monitoring. Their ultimate goal is to accelerate the process of identifying the right therapeutic target, patient population, and biomarkers for drug development.